Randomized Trialhigh evidence
International study of Coronary Microvascular Angina (iCorMicA): a registry-based diagnostic study and nested randomized trial.
American heart journal·July 6, 2026·PMID 42409349
Why it mattersANOCA is a common and debilitating condition, disproportionately affecting women, yet its underlying microvascular dysfunction is often unrecognized and untreated. This trial will provide evidence on whether disclosing coronary function test results to cardiologists improves angina-related quality of life, potentially informing a more personalized diagnostic and therapeutic approach.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled